Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Greer

Showing results (711-720 of 765) with videos related to

Pageof 77
Sort By:
Lancet (London, England)|October 27, 2018
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trialDésirée van der Heijde, Xenofon Baraliakos, Lianne S Gensler, et al.
Annals of Neurology|January 18, 2025
Quantitative Pupillometry Predicts Neurologic Deterioration in Patients with Large Middle Cerebral Artery StrokeYili Du, Jack E Pohlmann, Stefanos Chatzidakis, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|August 19, 2020
Subarachnoid hemorrhage guidance in the era of the COVID-19 pandemic - An opinion to mitigate exposure and conserve personal protective equipmentThanh N Nguyen, Ashutosh P Jadhav, Hormuzdiyar H Dasenbrock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical EfficacyJennifer R Diamond, Valentina Boni, Emerson Lim, et al.
Critical Care Explorations|July 5, 2022
Dexmedetomidine and Other Analgosedatives Alter Pupil Characteristics in Critically Ill PatientsWang Pong Chan, Brenton R Prescott, Megan E Barra, et al.
British Journal of Haematology|May 19, 2012
Phase 1 dose-escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemiasAmer M Zeidan, Rebecca M Ricklis, Hetty E Carraway, et al.
Critical Care Explorations|January 18, 2021
Postcardiac Arrest Neuroprognostication Practices: A Survey of Brazilian PhysiciansSonya E Zhou, Mary M Barden, Emily J Gilmore, et al.
Frontiers in Neurology|December 23, 2022
Quantitative pupillometry and radiographic markers of intracranial midline shift: A pilot studyIvy So Yeon Kim, Oluwafemi O Balogun, Brenton R Prescott, et al.
AJNR. American Journal of Neuroradiology|January 2, 2010
Functional contrast-enhanced CT for evaluation of acute ischemic stroke does not increase the risk of contrast-induced nephropathyF O Lima, M H Lev, R A Levy, et al.
Journal of Vascular and Interventional Neurology|October 10, 2014
Enrollment of research subjects through telemedicine networks in a multicenter acute intracerebral hemorrhage clinical trial: design and methodsJ Alfredo Caceres, David M Greer, Joshua N Goldstein, et al.
Pageof 77

Showing results (711-720 of 765) with videos related to

Sort By:
Pageof 77
Lancet (London, England)|October 27, 2018
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trialDésirée van der Heijde, Xenofon Baraliakos, Lianne S Gensler, et al.
Annals of Neurology|January 18, 2025
Quantitative Pupillometry Predicts Neurologic Deterioration in Patients with Large Middle Cerebral Artery StrokeYili Du, Jack E Pohlmann, Stefanos Chatzidakis, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|August 19, 2020
Subarachnoid hemorrhage guidance in the era of the COVID-19 pandemic - An opinion to mitigate exposure and conserve personal protective equipmentThanh N Nguyen, Ashutosh P Jadhav, Hormuzdiyar H Dasenbrock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical EfficacyJennifer R Diamond, Valentina Boni, Emerson Lim, et al.
Critical Care Explorations|July 5, 2022
Dexmedetomidine and Other Analgosedatives Alter Pupil Characteristics in Critically Ill PatientsWang Pong Chan, Brenton R Prescott, Megan E Barra, et al.
British Journal of Haematology|May 19, 2012
Phase 1 dose-escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemiasAmer M Zeidan, Rebecca M Ricklis, Hetty E Carraway, et al.
Critical Care Explorations|January 18, 2021
Postcardiac Arrest Neuroprognostication Practices: A Survey of Brazilian PhysiciansSonya E Zhou, Mary M Barden, Emily J Gilmore, et al.
Frontiers in Neurology|December 23, 2022
Quantitative pupillometry and radiographic markers of intracranial midline shift: A pilot studyIvy So Yeon Kim, Oluwafemi O Balogun, Brenton R Prescott, et al.
AJNR. American Journal of Neuroradiology|January 2, 2010
Functional contrast-enhanced CT for evaluation of acute ischemic stroke does not increase the risk of contrast-induced nephropathyF O Lima, M H Lev, R A Levy, et al.
Journal of Vascular and Interventional Neurology|October 10, 2014
Enrollment of research subjects through telemedicine networks in a multicenter acute intracerebral hemorrhage clinical trial: design and methodsJ Alfredo Caceres, David M Greer, Joshua N Goldstein, et al.
Pageof 77